Further, LKB1 inactivation induces a redox imbalance to promote transdifferentiation from lung adenocarcinoma to lung squamous cell carcinoma in NSCLC, which leads resistance to anti-tumor therapy [90]. Here, STK11 is linked to squamous cell lung carcinoma.